ELEVAI Skincare CEO to Present at Beauty Through Science Conference in Stockholm, Sweden
ELEVAI CEO Dr. Jordan Plews will speak about the exosomes landscape in aesthetics today along with their benefits in promoting the body’s natural repair processes.
ELEVAI Labs (NASDAQ: ELAB), a pioneering force in medical aesthetics, announced that Chief Executive Officer Jordan R. Plews, PhD has been invited back and will be presenting at the Beauty Through Science conference in Stockholm, Sweden on Thursday, May 30, 2024.
Beauty Through Science (BTS) is an annual event that gathers the greatest minds in aesthetic medicine to share the most up-to-date, innovative techniques and technologies within the field – in an immersive and intimate atmosphere. BTS was founded in 2002 and has gradually grown to host more than 1,000 participants from close to 50 countries, establishing itself as one of the most renowned aesthetic medical meetings in the world. Physicians, plastic surgeons and dermatologists, among other leading experts, share knowledge to promote a holistic approach between surgical and non-surgical procedures, focusing on the newest and best technologies.
Details
- What: Beauty Through Science Conference
- Where: Waterfront Congress Center – Stockholm, Sweden
- When: Thursday May 30, 2024
- Website: BtsStockholm.com
Read Now: ELEVAI Labs: A Strategic Expansion in Biosciences and Skincare
ELEVAI Labs expands reach with new distribution partnerships, licensing agreement for therapeutic assets targeting obesity and the formation of skincare and biosciences subsidiaries.
Dr. Plews will speak as part of the session titled “Exosomes: Key Considerations, Regulations and Results” to discuss the exosome landscape in aesthetics today along with the benefits of exosomes in promoting the body’s natural repair processes.
ELEVAI CEO, Dr. Jordan R. Plews, PhD commented on tomorrow’s conference, stating:
“ELEVAI is proud to be an official partner of Beauty Through Science 2024. I’m looking forward to sharing the latest on exosome technology and our science-driven, data-backed approach with the medical aesthetics and beauty community.”
Shares of ELEVAI Labs (NASDAQ: ELAB) last traded at $0.66, up +3.91% today.
Learn more about ELEVAI Labs: Website | Investor Deck | ELAB Chart
Follow ELEVAI on Social Media: Instagram | Facebook | LinkedIn | Twitter | YouTube
Join the Discussion in the Wealthy VC Investor Group
Have a Stock Tip or New Story Suggestion? Email us at Invest@WealthyVC.com
Elevai Labs Inc. is a paid client of Wealthy VC.
This report/release/profile is a commercial advertisement and is for general information purposes only. We are engaged in the business of marketing and advertising companies for monetary compensation unless otherwise stated below.
